"The Company notes a key factor to finalising an outcome being timing of the EIA regulatory
approval, whilst also noting the current challenging lithium market dynamics and pricing
affecting the process."
Seems that this is confirmation that we are waiting on the EIA to be approved before any offtake? (with the market conditions etc also taken into consideration).
- Forums
- ASX - By Stock
- AGY
- Ann: Quarterly Activities Report - December 2023
AGY
argosy minerals limited
Add to My Watchlist
20.0%
!
1.8¢

Ann: Quarterly Activities Report - December 2023, page-18
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
1.8¢ |
Change
0.003(20.0%) |
Mkt cap ! $26.20M |
Open | High | Low | Value | Volume |
1.6¢ | 2.3¢ | 1.6¢ | $899.2K | 44.43M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
11 | 1745031 | 1.8¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.0¢ | 1134176 | 6 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
9 | 1045031 | 0.018 |
6 | 504117 | 0.017 |
10 | 1438810 | 0.016 |
15 | 2554023 | 0.015 |
33 | 4049845 | 0.014 |
Price($) | Vol. | No. |
---|---|---|
0.020 | 1043916 | 5 |
0.021 | 880234 | 9 |
0.022 | 1464025 | 8 |
0.023 | 4200866 | 8 |
0.024 | 2694809 | 10 |
Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
Featured News
AGY (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online